Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Myriad Genetics (MYGN) Other Non-Current Liabilities: 2010-2025

Historic Other Non-Current Liabilities for Myriad Genetics (MYGN) over the last 15 years, with Sep 2025 value amounting to $1.7 million.

  • Myriad Genetics' Other Non-Current Liabilities fell 95.04% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year decrease of 95.04%. This contributed to the annual value of $2.2 million for FY2024, which is 94.67% down from last year.
  • Per Myriad Genetics' latest filing, its Other Non-Current Liabilities stood at $1.7 million for Q3 2025, which was down 10.53% from $1.9 million recorded in Q2 2025.
  • Myriad Genetics' Other Non-Current Liabilities' 5-year high stood at $43.9 million during Q4 2022, with a 5-year trough of $1.7 million in Q3 2025.
  • In the last 3 years, Myriad Genetics' Other Non-Current Liabilities had a median value of $11.5 million in 2023 and averaged $20.2 million.
  • Its Other Non-Current Liabilities has fluctuated over the past 5 years, first skyrocketed by 253.04% in 2024, then slumped by 95.07% in 2025.
  • Myriad Genetics' Other Non-Current Liabilities (Quarterly) stood at $32.1 million in 2021, then surged by 36.76% to $43.9 million in 2022, then fell by 5.92% to $41.3 million in 2023, then crashed by 94.67% to $2.2 million in 2024, then crashed by 95.04% to $1.7 million in 2025.
  • Its Other Non-Current Liabilities was $1.7 million in Q3 2025, compared to $1.9 million in Q2 2025 and $2.0 million in Q1 2025.